Published in Anesthesiology on February 01, 1979
A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology (1994) 3.23
Purification of an exo-beta-D-(1 bonded to 3)-glucanase from Basidiomycete species QM 806. J Biol Chem (1968) 2.30
Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol (1997) 1.65
Current concepts. The malignant hyperthermia syndrome. N Engl J Med (1983) 1.43
Studies on the action of amylo-I,6-glucosidase. Biochim Biophys Acta (1970) 1.39
Ability of different physical activity monitors to detect movement during treadmill walking. Int J Sports Med (2003) 1.39
Separation and characterization of the soluble and insoluble components of insoluble laminaran. Carbohydr Res (1974) 1.31
Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol (1992) 1.20
Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest (1983) 1.19
Action pattern and specificity of an exo-beta-(1--3)-D-glucanase from basidiomycetes species QM 806. J Biol Chem (1969) 1.18
Malignant hyperthermia and apparent heat stroke. JAMA (2001) 1.16
Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology (1983) 1.15
Association of gylcogenolysis with cardiac sarcoplasmic reticulum. J Biol Chem (1976) 1.02
Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am J Hum Genet (2001) 1.02
Malignant hyperthermia of Poland China swine: studies of a myogenic etiology. Anesthesiology (1972) 1.01
The transient depression of hippocampal CA1 LTP induced by chronic intermittent ethanol exposure is associated with an inhibition of the MAP kinase pathway. Eur J Neurosci (2003) 1.00
[3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermia. J Biol Chem (1992) 1.00
Evaluation of suspected osteoid osteoma. Clin Orthop Relat Res (1996) 0.99
Purification and properties of rabbit muscle amylo-1,6-glucosidase-oligo-1,4-1,4-transferase. Biochemistry (1969) 0.98
Long-term potentiation in the rat hippocampus is reversibly depressed by chronic intermittent ethanol exposure. J Neurophysiol (2002) 0.98
Carnosine is a novel peptide modulator of intracellular calcium and contractility in cardiac cells. Am J Physiol (1997) 0.97
Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle. Biophys J (1991) 0.97
Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle. Anesthesiology (1975) 0.97
The hydrolytic mechanism of an exo-beta-(1--3)-D-glucanase. J Biol Chem (1970) 0.97
Malignant hyperthermia of swine. Anesthesiology (1972) 0.94
Identification and functional characterization of a novel ryanodine receptor mutation causing malignant hyperthermia in North American and South American families. Neuromuscul Disord (2001) 0.93
Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme. Biochemistry (1977) 0.89
Re-evaluation of the subunit structure and molecular weight of rabbit muscle amylo-1,6-glucosidase-4-alpha-glucanotransferase. Biochim Biophys Acta (1974) 0.89
Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr (1982) 0.89
Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology (2001) 0.89
The action of the glycogen debranching enzyme system in a muscle protein particle. Biochem Biophys Res Commun (1972) 0.89
Porcine malignant hyperthermia: a study on the triggering effects of succinylcholine. Anesth Analg (1974) 0.88
Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomer-selective inhibition of L-type Ca(2+) channels? Anesth Analg (2001) 0.87
Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia. Clin Exp Pharmacol Physiol (1977) 0.87
North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Anesthesiology (2001) 0.86
Annexin VI is associated with calcium-sequestering organelles. J Cell Biochem (1991) 0.84
The attack mechanism of an exo-1,3-beta-glucosidase from Basidiomycete sp. QM 806. Biochim Biophys Acta (1975) 0.84
Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs. Am J Vet Res (1974) 0.84
Spectrum of susceptibility to malignant hyperthermia--diagnostic dilemma. Anesth Analg (1983) 0.83
Somatic Ca2+ signaling in cerebellar Purkinje neurons. J Neurosci Res (2010) 0.83
Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs. J Pharmacol Exp Ther (1981) 0.82
Thyroxine modulation of epinephrine stimulated secretion of rat parotid -amylase. Biochem Biophys Res Commun (1972) 0.82
Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology (1980) 0.82
A rapid micro assay method for amylo-1,6-glucosidase. Anal Biochem (1970) 0.82
Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion. Tex Rep Biol Med (1979) 0.81
Screening for malignant hyperpyrexia. Br J Anaesth (1977) 0.81
Massive postoperative rhabdomyolysis after uneventful surgery: a case report of subclinical malignant hyperthermia. Anesthesiology (1998) 0.81
Porcine malignant hyperthermia. Am J Pathol (1976) 0.81
The use of MRI in the diagnosis of benign and malignant bone and soft tissue tumours. Australas Radiol (1993) 0.80
Comparison of Ca++ uptake and spontaneous Ca++ release from sarcoplasmic reticulum vesicles isolated from muscle of malignant hyperthermia diagnostic patients. J Pharmacol Exp Ther (1987) 0.80
The rate of wound healing is increased in psoriasis. J Dermatol Sci (2013) 0.80
Malignant melanoma: Mayo Clinic experience. Mayo Clin Proc (1997) 0.80
Ryanodine: antithetical calcium channel effects in skeletal muscle sarcoplasmic reticulum. J Pharmacol Exp Ther (1987) 0.80
Thiol/disulfide redox equilibrium between glutathione and glycogen debranching enzyme (amylo-1,6-glucosidase/4-alpha-glucanotransferase) from rabbit muscle. J Biol Chem (1986) 0.79
Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients? Anesth Analg (1983) 0.79
Reinvestigation of the pH optimum in terms of the action and properties of rabbit muscle amylo-1,6-glucosidase-oligo-1,4 to 1,4-transferase. Biochim Biophys Acta (1968) 0.79
Purification of glycogen debranching enzyme from rabbit muscle using omega-aminoalkyl agarose chromatography. Anal Biochem (1981) 0.79
Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility? Anesth Analg (1984) 0.78
Carnosine: a novel peptide regulator of intracellular calcium and contractility in cardiac muscle. New Horiz (1996) 0.78
Central core disease and malignant hyperthermia syndrome. Ann Neurol (1980) 0.78
Estrogen and prothrombin synthesis: effect of estrogen on absorption of vitamin K1. Am J Physiol (1977) 0.78
Malignant hyperthermia--diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesth Analg (1994) 0.77
Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect). Can Anaesth Soc J (1980) 0.77
Urea toxicity studies in the bovine. J Anim Sci (1969) 0.77
Malignant hyperthermia: is etomidate safe? Anesth Analg (1985) 0.77
Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle. J Clin Invest (1979) 0.77
Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle. FEBS Lett (1984) 0.76
Malignant hyperthermia: a disease of specific myofiber type? Can Anaesth Soc J (1982) 0.76
Analytical gel chromatography of rabbit muscle amylo-1,6-glucosidase/4-alpha-glucanotransferase under denaturing and non-denaturing conditions. Biochim Biophys Acta (1975) 0.75
Diagnosing malignant hyperthermia. Plast Reconstr Surg (1989) 0.75
Combined caffeine-halothane test for malignant hyperthermia. Br J Anaesth (1993) 0.75
In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermia. Can Anaesth Soc J (1980) 0.75
Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia. Anesthesiology (1984) 0.75
Specificity of an isolated salivary factor material to cystic fibrosis. Pediatr Res (1981) 0.75
Estrogen and prothrombin synthesis. The prothrombinogenic action of estrogen. Biochem Biophys Res Commun (1977) 0.75
Creatine supplementation and swimming performance. Int J Sport Nutr (1999) 0.75
Cystic fibrosis: isolation and physical properties of a salivary cystic fibrosis factor. Pediatr Res (1978) 0.75
The effect of denaturing conditions on the activity of rabbit muscle amylo-1,6-glucosidase-oligo-1,4 leads to 1,4-glucantransferase. Mol Cell Biochem (1974) 0.75
Biphasic adrenergic responses of rabbit aorta. Microvasc Res (1974) 0.75
Amylo-1,6-glucosidase/4-alpha-glucanotransferase. Reaction of rabbit muscle debranching enzyme with an active site-directed irreversible inhibitor, 1-S-dimethylarsino-1-thio-beta-D-glucopyranoside. J Biol Chem (1980) 0.75
Malignant hyperthermia. Anesth Analg (1980) 0.75
Ponderal index: quantifying obesity. JAMA (1979) 0.75
Cystic fibrosis: enzymatic detection of a ciliostatic factor. Pediatr Res (1976) 0.75
Calcium and magnesium content of skeletal muscle. Studies in subjects undergoing diagnostic testing for malignant hyperthermia. Br J Anaesth (1987) 0.75
Effect of dantrolene on neouromuscular block by d-tubocurarine and subsequent antagonism by neostigmine in the rabbit. Anesthesiology (1980) 0.75
Prolonged electromechanical coupling time intervals in skeletal muscle of pigs susceptible to malignant hyperthermia. Muscle Nerve (1983) 0.75
Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle. J Pharmacol Exp Ther (1997) 0.75
Treatment of malignant hyperthermia in swine. Anesth Analg (1973) 0.75
Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility? Can Anaesth Soc J (1979) 0.75
Letter: Malignant hyperthermia. JAMA (1976) 0.75
Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. Can Anaesth Soc J (1982) 0.75